GYRE THERAPEUTICS, INC.

Other languages Gyre Therapeutics, Inc.

Equities

GYRE

US4037831033

End-of-day quote Nasdaq Other stock markets 03:30:00 18/06/2024 am IST			5-day change	1st Jan Change
10.8 ^USD	-6.33%		-2.17%	-57.96%

18/06	Gyre Therapeutics, Inc. Announces Publication of Liver Fibrosis in Journal of Gastroenterology and Hepatology	CI
31/05	Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gyre Therapeutics, Inc. Announces Publication of Liver Fibrosis in Journal of Gastroenterology and Hepatology	19/06
Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy	31/05
Gyre Pharmaceuticals Receives IND Approval from China?s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension	31/05
Gyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing	04/04
Gyre Therapeutics Swings to Fiscal 2023 Net Loss, Revenue Rises	26/03
Gyre Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Gyre Therapeutics Announces Appointment of Rodney L. Nussbaum to the Board of Directors and Member of Audit Committee	21/03
Gyre Therapeutics, Inc. Announces Board Changes	20/01
Gyre Therapeutics, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	13/01
Gyre Therapeutics, Inc. Announces CEO Changes, Effective January 15, 2024	16/12
Gyre Therapeutics, Inc. and Beijing Continent Pharmaceuticals Co., Ltd. Announce the Resignation of Charles Wu as Member of the Board of Directors. Effective on January 15, 2024	16/12
Gyre Therapeutics, Inc. Announces Management Changes	31/23/31
Gyre Therapeutics, Inc. Announces Management Changes	31/23/31
Gyre Therapeutics, Inc. Announces CEO Changes	31/23/31
Gyre Therapeutics, Inc. Announces Management Changes	31/23/31
Gyre Therapeutics, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	14/23/14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer